Evaluation of specific delivery of chimeric phi29 p RNA/siRNA nanoparticles to multiple tumor cells

L Li, J Liu, Z Diao, D Shu, P Guo, G Shen - Molecular BioSystems, 2009 - pubs.rsc.org
The pRNA (packaging RNA) of bacteriophage phi29 DNA packaging motor has been
reported to have novel applications in nanotechnology and nanomedicine. The unique …

Targeted nanoparticles harboring jasmine-oil-entrapped paclitaxel for elimination of lung cancer cells

S Engelberg, Y Lin, YG Assaraf, YD Livney - International Journal of …, 2021 - mdpi.com
Selectively targeted drug delivery systems are preferable chemotherapeutic platforms, as
they specifically deliver the drug cargo into tumor cells, while minimizing untoward toxic …

Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line

H Montazeri Aliabadi, B Landry… - Molecular …, 2011 - ACS Publications
Post-transcriptional silencing of antiapoptotic genes is a promising strategy for cancer
therapy, but delivering short interfering RNA (siRNA) molecules against such targets is …

Biodistribution and Pharmacokinetics of Mad2 siRNA-loaded EGFR-Targeted Chitosan Nanoparticles in Cisplatin Sensitive and Resistant Lung Cancer Models

AV Nascimento, F Gattacceca, A Singh, H Bousbaa… - …, 2016 - Taylor & Francis
Background: The present study focuses on biodistribution profile and pharmacokinetic
parameters of EGFR-targeted chitosan nanoparticles (TG CS nanoparticles) for …

Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression

Z Khan, RP Tiwari, N Khan, G BKS Prasad… - Current gene …, 2012 - ingentaconnect.com
Survivin is known to be highly-expressed in various carcinomas; and is associated with their
biologically aggressive characteristics and drug resistance. We have previously reported …

5′-triphosphate-siRNA against survivin gene induces interferon production and inhibits proliferation of lung cancer cells in vitro

K Wang, X Chen, F Yan, Y Xing, X Yang… - Journal of …, 2013 - journals.lww.com
Survivin is a new member of the inhibitors of apoptosis family and upregulated in various
human malignancies including human lung cancer. In this study, we proposed a new …

Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery …

S Ni, Y Xie, Y Tang, Y Liu, J Chen… - Journal of Drug Targeting, 2017 - Taylor & Francis
This study developed a pH-sensitive anionic system composed of guanidinylated O-
carboxymethyl chitosan (GOCMCS) and N-2-hydroxypropyltimehyl ammonium chloride …

Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells

VP Gibson, RM Derbali, HT Phan, H Tahiri… - International Journal of …, 2020 - Elsevier
Survivin stands out as one of the most specific cancer targets discovered to date. Although
single inhibition, eg through small interfering RNA (siRNA), has shown modest results in …

Combination Nanopreparations of a Novel Proapoptotic Drug–NCL-240, TRAIL and siRNA

R Riehle, B Pattni, A Jhaveri, A Kulkarni… - Pharmaceutical …, 2016 - Springer
Purpose To develop a multifunctional nanoparticle system carrying a combination of pro-
apoptotic drug, NCL-240, TRAIL [tumor necrosis factor-α (TNF-α)-related apoptosis-inducing …

Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents

S Trabulo, AM Cardoso, T Santos-Ferreira… - Molecular …, 2011 - ACS Publications
Since clinical application of conventional cancer therapies is usually limited by drug
resistance and toxic side effects, combination of chemotherapeutic agents with gene therapy …